ticagrelor

Generic: ticagrelor

Labeler: oryza pharmaceuticals, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name ticagrelor
Generic Name ticagrelor
Labeler oryza pharmaceuticals, inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

ticagrelor 60 mg/1

Manufacturer
Oryza Pharmaceuticals, Inc.

Identifiers & Regulatory

Product NDC 72516-017
Product ID 72516-017_461d8570-9132-90a2-e063-6294a90abb5a
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA208508
Listing Expiration 2026-12-31
Marketing Start 2025-12-01

Pharmacologic Class

Established (EPC)
p2y12 platelet inhibitor [epc]
Mechanism of Action
p2y12 receptor antagonists [moa] cytochrome p450 3a4 inhibitors [moa] p-glycoprotein inhibitors [moa]
Physiologic Effect
decreased platelet aggregation [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 72516017
Hyphenated Format 72516-017

Supplemental Identifiers

RxCUI
1666332
UPC
0372516017064
UNII
GLH0314RVC
NUI
N0000182142 N0000008832 N0000182143 N0000182141 N0000185503

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name ticagrelor (source: ndc)
Generic Name ticagrelor (source: ndc)
Application Number ANDA208508 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 60 mg/1
source: ndc
Packaging
  • 60 TABLET in 1 BOTTLE (72516-017-06)
source: ndc

Packages (1)

72516-017-06 60 TABLET in 1 BOTTLE (72516-017-06)

Ingredients (1)

ticagrelor (60 mg/1)

Linked Drug Pages (1)

Ticagrelor ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "461d8570-9132-90a2-e063-6294a90abb5a", "openfda": {"nui": ["N0000182142", "N0000008832", "N0000182143", "N0000182141", "N0000185503"], "upc": ["0372516017064"], "unii": ["GLH0314RVC"], "rxcui": ["1666332"], "spl_set_id": ["461d810e-5b77-5e53-e063-6294a90a64b0"], "pharm_class_pe": ["Decreased Platelet Aggregation [PE]"], "pharm_class_epc": ["P2Y12 Platelet Inhibitor [EPC]"], "pharm_class_moa": ["P2Y12 Receptor Antagonists [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "manufacturer_name": ["Oryza Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET in 1 BOTTLE (72516-017-06)", "package_ndc": "72516-017-06", "marketing_start_date": "20251201"}], "brand_name": "Ticagrelor", "product_id": "72516-017_461d8570-9132-90a2-e063-6294a90abb5a", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 3A4 Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "P-Glycoprotein Inhibitors [MoA]", "P2Y12 Platelet Inhibitor [EPC]", "P2Y12 Receptor Antagonists [MoA]"], "product_ndc": "72516-017", "generic_name": "Ticagrelor", "labeler_name": "Oryza Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Ticagrelor", "active_ingredients": [{"name": "TICAGRELOR", "strength": "60 mg/1"}], "application_number": "ANDA208508", "marketing_category": "ANDA", "marketing_start_date": "20251201", "listing_expiration_date": "20261231"}